Medicine

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

G. Giovannoni, B. Turner, S. Gnanapavan, C. Offiah, K. Schmierer, M. Marta

2015.7.1Multiple Sclerosis and Related Disorders

DOI: 10.1016/j.msard.2015.04.006

tlooto Summary

This work proposes a new treatment paradigm that individualises treatment based on a choice between two interchangeable therapeutic strategies of maintenance-escalation or induction therapy, and proposes treating- to-target of no evident disease activity (NEDA) as defined using clinical and MRI criteria.

Abstract

Abstract is not available.

Citation format

GIOVANNONI, G., et al. Is it time to target no evident disease activity (NEDA) in multiple sclerosis? Multiple Sclerosis and Related Disorders, 2015, 4 4: 329–33.